Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ting Cui

Showing results (231-240 of 232) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 232 results.
Human Vaccines & Immunotherapeutics|October 26, 2023
Safety, tolerability, and immunogenicity of a CpG/Alum adjuvanted SARS-CoV-2 recombinant protein vaccine (ZR202-CoV) in healthy adults: Preliminary report of a phase 1, randomized, double-blind, placebo-controlled, dose-escalation trialGuang-Wei Feng, Zhong-Fang Wang, Peng He, et al.
Helicobacter|April 12, 2023
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in NingxiaShengjuan Hu, Yan Zhou, Yanhong Deng, et al.
Pageof 24

Showing results (231-240 of 232) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 232 results.
Human Vaccines & Immunotherapeutics|October 26, 2023
Safety, tolerability, and immunogenicity of a CpG/Alum adjuvanted SARS-CoV-2 recombinant protein vaccine (ZR202-CoV) in healthy adults: Preliminary report of a phase 1, randomized, double-blind, placebo-controlled, dose-escalation trialGuang-Wei Feng, Zhong-Fang Wang, Peng He, et al.
Helicobacter|April 12, 2023
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in NingxiaShengjuan Hu, Yan Zhou, Yanhong Deng, et al.
Pageof 24